Most Clicked StoriesMore >


Adding dapagliflozin to metformin/sulfonylurea yields better results

DiabetesPro SmartBrief | Jan 30, 2015

Type 2 diabetes patients who used dapagliflozin as an add-on to metformin/sulfonylurea treatment attained better A1C levels at 24 weeks than those in the placebo cohort, researchers reported in Diabetes Care. Patients in the intervention arm also showed lower fasting plasma glucose, systolic blood pressure and body weight compared with the controls. Healio (free registration) (01/29)


Study: Self-management program may improve diabetes distress

DiabetesPro SmartBrief | Jan 27, 2015

Peripheral neuropathy in type 1 diabetes can be predicted with technique

DiabetesPro SmartBrief | Jan 26, 2015

Lower-protein diet may be risky for obese adults with diabetes

DiabetesPro SmartBrief | Jan 29, 2015

Glucose monitoring apps receive marketing approval from FDA

DiabetesPro SmartBrief | Jan 27, 2015

Study ties leisure-time workout to lower CV risk in CAD, diabetes

DiabetesPro SmartBrief | Jan 28, 2015

Diabetes Timeline

DiabetesPro SmartBrief | Jan 28, 2015

Study shows support for diabetes education programs at work

DiabetesPro SmartBrief | Jan 28, 2015

Patients offer feedback on diabetes education approaches

DiabetesPro SmartBrief | Jan 29, 2015

High consumption of added sugars worsens diabetes risk, experts say

DiabetesPro SmartBrief | Jan 30, 2015


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


ConnecT2Day: Innovative Program Providing Key Insights and Tools for Health Care Professionals

DiabetesPro SmartBrief | Jan 30, 2015

Pathway to Stop Diabetes Call for Nominations now open

DiabetesPro SmartBrief | Jan 29, 2015

Diabetes Timeline

DiabetesPro SmartBrief | Jan 28, 2015

Core Research Program 2015 Call for Applications now open!

DiabetesPro SmartBrief | Jan 27, 2015

New! DiabetesPro Career Center

DiabetesPro SmartBrief | Jan 26, 2015




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.